NPY and Anxiety: Implicating NPY in depression-like phenotypes, administration of the NPY Y1 receptor agonist NPY (Leu31, Pro34) had anxiolytic and antidepressant effects on cholecystokinin-4 (CCK-4)-induced anxiety-like behavior in the SIT and depression-like behavior in the FST (165).